Skip to main content

Advertisement

Table 1 Clinical information of hepatoblastoma cases

From: Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma

Case Sex/agea Histology PRETEXT Preoperative chemotherapyb POSTTEXT Outcome Other information
HB01 F/1y3m Combined fetal and embryonal type III CITA4 III Alive  
HB02 F/3y2m Fetal typec III CITA4 III Aive  
HB03 F/7y11m Hepatoblastoma (NOS)d III CITA5 III Alive Small for gestational age
HB04 M/1y4m Mixed epithelial and mesenchymal with teratoid featurec IV CITA4 + ITEC2 IV Alive  
HB05 M/1y2m Mixed epithelial and mesenchymal with teratoid feature III CITA5 II Alive  
HB06 M/10m Mixed epithelial and mesenchymal with teratoid feature III CITA4 III Alive  
HB07 M/8m Combined fetal and embryonal type II CITA2 II Alive  
HB08 F/28d Combined fetal and embryonal type II    Alive  
HB09 M/1y6m Combined fetal and embryonal type II    Treatment related death Small for gestational age
HB10 F/6y6m Fetal type II CITA2 II Alive  
HB11 F/3m Combined fetal and embryonal type IV CITA7 III Treatment related death  
BWS109 F/1y0m Hepatoblastoma (NOS)d IV,M(+) CITA7 + ITEC1 IV Alive Beckwith-Wiedemann syndrome, liver transplantation at 1 year old
  1. aage at diagnosis, bCITA: cisplatin-pirarubicin, ITEC: Ifosfamide, pirarubicin, etoposide, and carboplatin. The numerals indicate the cycle numbers of the chemotherapy. cdifficult to diagnose due to chemotherapy, dnot otherwise specified.